A Mass Spectrometry System for Quantitative Proteomics
用于定量蛋白质组学的质谱系统
基本信息
- 批准号:8640415
- 负责人:
- 金额:$ 56.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnaphylaxisAreaBacterial InfectionsBiologicalBiomedical ResearchChlamydiaCircadian RhythmsClock proteinCommunitiesDiabetes MellitusDigestionDigestive System DisordersEpitopesFundingHealthHepatitis C virusHumanLife Cycle StagesLiquid ChromatographyLysosomesMalignant NeoplasmsMass Spectrum AnalysisNeurodegenerative DisordersPost-Translational Protein ProcessingProteinsProteomicsRequest for ApplicationsResearchResearch PersonnelRetroviridaeRoleSimulateSleep DisordersStagingStomachSystemSystems BiologyTumor Suppressor ProteinsUnited States National Institutes of HealthUniversitiesVirus DiseasesWood materialfood allergeninstrumentinstrumentationmass spectrometermedical schoolsnervous system disorderpathogenresearch studytumorigenesis
项目摘要
DESCRIPTION (provided by applicant): This is an application requesting funds to purchase a Q Exactive mass spectrometer and liquid chromatography system that will be used for quantitative proteomics research. The instrument will be integrated into the Robert Wood Johnson Medical School/Rutgers University Biological Mass Spectrometry Facility. Current instrumentation in the Facility is used at maximal capacity and we require additional capabilities to conduct quantitative proteomics experiments for thirteen NIH-funded investigators. Our user group will apply quantitative mass spectrometry to most efficiently address a wide range of important biomedical research areas including neurological disease, bacterial and viral infection, cancer, anaphylaxis, diabetes, digestive disease, and sleep disorders. Specific experiments include quantification of changes in levels and post-translational modifications of clock proteins throughout the circadian cycle, a systems biology approach to understand the lysosome and its role in human neurodegenerative disease, persistence of epitopes on protein food allergens under conditions that simulate gastric digestion, dynamics of post- translational modification of tumor suppressors during oncogenesis and analysis of pathogen-host interactions at different stages in their life cycle for hepatitis C virus, retroviruses, and chlamydia.. The requested instrument will therefore represent a significant asset to our research community and will accelerate the pace of basic and applied NIH-funded health-research at Rutgers University and the Robert Wood Johnson Medical School of UMDNJ.
描述(由申请人提供):这是一项申请,要求资金购买Q精确的质谱仪和液相色谱系统,该系统将用于定量蛋白质组学研究。该乐器将集成到罗伯特·伍德·约翰逊医学院/罗格斯大学生物学质谱设施中。该设施中的当前仪器以最大能力使用,我们需要其他功能来为13名NIH资助的研究人员进行定量蛋白质组学实验。我们的用户组将使用定量质谱法来最有效地解决广泛的重要生物医学研究领域,包括神经系统疾病,细菌和病毒感染,癌症,过敏反应,糖尿病,消化系统疾病和睡眠障碍。具体的实验包括量化水平的变化和整个昼夜节律的平时蛋白质的变化和翻译后的修饰,一种系统生物学方法,以了解溶酶体及其在人类神经退行性疾病中的作用及其在蛋白质食物过敏剂对蛋白质过敏剂的持久性在胃挖掘和分析剂量的抑制作用后,蛋白质食物过敏剂的持久性,在蛋白质过敏剂中进行了分析。因此,在其生命周期中,丙型肝炎病毒,逆转录病毒和衣原体。因此,所请求的工具将代表我们的研究社区的重要资产,并将加速Rutgers University和Robert Wood Johnson Medical School of Umdnj的基本和应用NIH资助的健康研究的步伐。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A multipronged approach unravels unprecedented protein-protein interactions in the human 2-oxoglutarate dehydrogenase multienzyme complex.
多管齐下的方法揭示了人类 2-酮戊二酸脱氢酶多酶复合物中前所未有的蛋白质-蛋白质相互作用。
- DOI:10.1074/jbc.ra118.005432
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Zhou,Jieyu;Yang,Luying;Ozohanics,Oliver;Zhang,Xu;Wang,Junjie;Ambrus,Attila;Arjunan,Palaniappa;Brukh,Roman;Nemeria,NataliaS;Furey,William;Jordan,Frank
- 通讯作者:Jordan,Frank
Elemental sulfur reduction in the deep-sea vent thermophile, Thermovibrio ammonificans.
深海喷口嗜热菌、氨化热弧菌中元素硫的还原。
- DOI:10.1111/1462-2920.14280
- 发表时间:2018
- 期刊:
- 影响因子:5.1
- 作者:Jelen,Benjamin;Giovannelli,Donato;Falkowski,PaulG;Vetriani,Costantino
- 通讯作者:Vetriani,Costantino
Structural and Dynamic Properties of Allergen and Non-Allergen Forms of Tropomyosin.
- DOI:10.1016/j.str.2018.05.002
- 发表时间:2018-07-03
- 期刊:
- 影响因子:0
- 作者:James JK;Pike DH;Khan IJ;Nanda V
- 通讯作者:Nanda V
Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells.
- DOI:10.1099/jgv.0.000716
- 发表时间:2017-04
- 期刊:
- 影响因子:0
- 作者:Kobayashi Y;Gélinas C;Dougherty JP
- 通讯作者:Dougherty JP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER LOBEL其他文献
PETER LOBEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER LOBEL', 18)}}的其他基金
Evaluation of the lysosomal protease tripeptidyl peptidase 1 as a potential therapeutic for Alzheimer Disease
溶酶体蛋白酶三肽基肽酶 1 作为阿尔茨海默病潜在治疗剂的评估
- 批准号:
9808153 - 财政年份:2019
- 资助金额:
$ 56.13万 - 项目类别:
Lysosomal Enzymes and Associated Human Genetic Diseases
溶酶体酶和相关人类遗传疾病
- 批准号:
8709755 - 财政年份:2013
- 资助金额:
$ 56.13万 - 项目类别:
Lysosomal Enzymes and Associated Human Genetic Diseases
溶酶体酶和相关人类遗传疾病
- 批准号:
7992517 - 财政年份:2010
- 资助金额:
$ 56.13万 - 项目类别:
MALDI TOF TOF MASS SPECTROMETER: CELL BIOLOGY
MALDI TOF TOF 质谱仪:细胞生物学
- 批准号:
7166385 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
MALDI TOF TOF MASS SPECTROMETER: GENETICS
MALDI TOF TOF 质谱仪:遗传学
- 批准号:
7166384 - 财政年份:2005
- 资助金额:
$ 56.13万 - 项目类别:
TANDEM MASS SPECTROMETER: STRUCTURE OF HIV REVERSE TRANSCRIPTASE WITH SUBSTRATES
串联质谱仪:HIV 逆转录酶与底物的结构
- 批准号:
6973244 - 财政年份:2004
- 资助金额:
$ 56.13万 - 项目类别:
相似国自然基金
类过敏反应关键受体MrgX2拮抗型小分子荧光探针的构建及其可视化分析研究
- 批准号:82373830
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
阳和定喘方介导NRP1-ST2信号通路抑制ILC2s活化抗哮喘气道过敏反应的机制研究
- 批准号:82274429
- 批准年份:2022
- 资助金额:49.00 万元
- 项目类别:面上项目
CXCL13在尘螨诱发呼吸道过敏反应中的作用及其机制分析
- 批准号:82260323
- 批准年份:2022
- 资助金额:35 万元
- 项目类别:地区科学基金项目
阳和定喘方介导NRP1-ST2信号通路抑制ILC2s活化抗哮喘气道过敏反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:49 万元
- 项目类别:面上项目
环境污染物PNMC调节鼻黏膜上皮干细胞特性诱发鼻过敏反应的作用和机理研究
- 批准号:82171120
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Postnatal and Prenatal Therapeutic Base Editing for Metabolic Diseases
代谢性疾病的产后和产前治疗碱基编辑
- 批准号:
10668614 - 财政年份:2023
- 资助金额:
$ 56.13万 - 项目类别:
IgE Suppressing Berberine Nanomedicine for Treatment of Peanut and Tree nut Allergies
抑制 IgE 的小檗碱纳米药物用于治疗花生和坚果过敏
- 批准号:
10649110 - 财政年份:2023
- 资助金额:
$ 56.13万 - 项目类别:
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10670058 - 财政年份:2022
- 资助金额:
$ 56.13万 - 项目类别:
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10353468 - 财政年份:2022
- 资助金额:
$ 56.13万 - 项目类别:
Patient-Centered Outcomes of the First Approved Peanut Allergy Treatment
首个获批的花生过敏治疗以患者为中心的结果
- 批准号:
10535462 - 财政年份:2021
- 资助金额:
$ 56.13万 - 项目类别: